Bruker (BRKR) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Bruker (BRKR) over the last 16 years, with Q3 2025 value amounting to $0.82.
- Bruker's Debt to Equity fell 3485.77% to $0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.82, marking a year-over-year decrease of 3485.77%. This contributed to the annual value of $1.17 for FY2024, which is 2682.29% up from last year.
- Latest data reveals that Bruker reported Debt to Equity of $0.82 as of Q3 2025, which was down 3485.77% from $1.34 recorded in Q2 2025.
- In the past 5 years, Bruker's Debt to Equity ranged from a high of $1.34 in Q2 2025 and a low of $0.76 during Q3 2021
- Moreover, its 5-year median value for Debt to Equity was $1.08 (2022), whereas its average is $1.06.
- Its Debt to Equity has fluctuated over the past 5 years, first surged by 6035.55% in 2022, then crashed by 3485.77% in 2025.
- Bruker's Debt to Equity (Quarter) stood at $1.23 in 2021, then dropped by 11.96% to $1.08 in 2022, then fell by 15.16% to $0.92 in 2023, then grew by 26.82% to $1.17 in 2024, then fell by 29.64% to $0.82 in 2025.
- Its Debt to Equity was $0.82 in Q3 2025, compared to $1.34 in Q2 2025 and $1.15 in Q1 2025.